The Weis Lab employs a hybrid experimental/computational approach towards characterizing disease, employing tools of imaging, biophysics, and computational modeling to study disease progression and response to therapy in cancer and intestinal diseases.
Research spans the length scale of disease from preclinical in vitro and in vivo model systems to translational clinical-based investigations within the scope of several overarching projects:
Imaging and biophysical computational characterization methods within the Weis Lab have been recently extended to study the developing gastrointestinal system under a multi-disciplinary team-science approach. In this work, we are developing and deploying new advanced non-invasive imaging and image analysis methods for intestinal disease within the neonatal setting using photoacoustic imaging. The extension of quantitative imaging characterization methodology development to study intestinal health and disease into this setting presents significant translational opportunity to improve quality of care in neonatal and pediatric patients. We are actively developing imaging-based measurement methods to assess intestinal vascular and motility function as diagnostic imaging biomarkers of neonatal intestinal disease for necrotizing enterocolitis in preclinical and clinical studies.
Mechanical investigations within the Weis Lab have also been recently extended to study the cardiotoxicity of cancer treatments from a mechanics and mathematical modeling background to explore tissue-level mechanical stiffness imaging biomarkers in the heart. The Weis Lab has developed novel computational methodologies to assess tissue-level mechanical elasticity in the left ventricle based on cine magnetic resonance images collected throughout the cardiac cycle.